PIM1 is upregulated consistently in the fibrotic lung tissues of IPF patients and in mice’s lungs induced by intratracheal BLM administration; treatment with ABI-171 significantly reduced the level of this enzyme (Figure 2I). The gene discussed is PIM1; the disease is idiopathic pulmonary fibrosis.